SCHEMBL35211532

SCHEMBL35211532

CC(C)c1ccc([I+]c2ccc(C(C)C)cc2)cc1.F[P-](F)(F)(F)(F)F

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TYR P14679 2/20 0.38
HTT P42858 2/20 0.35
HPGD P15428 1/20 0.35
IDO1 P14902 2/20 0.34
SMN1; SMN2 Q16637 3/20 0.33
MGLL Q99685 1/20 0.33
ALDH1A1 P00352 1/20 0.33
CYP2C9 P11712 2/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
GRIN2D O15399 1/20 0.32
GRIN3B O60391 1/20 0.32
GRIN1 Q05586 1/20 0.32
GRIN2A Q12879 1/20 0.32
GRIN2B Q13224 1/20 0.32
GRIN2C Q14957 1/20 0.32
GRIN3A Q8TCU5 1/20 0.32
SIGMAR1 Q99720 1/20 0.32
CYP2D6 P10635 1/20 0.32
HIF1A Q16665 1/20 0.32
LMNA P02545 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29360264 0.92 ACHE (0.36) TYRHTTHPGDSMN1; SMN2LMNA
SCHEMBL4190526 0.90 TYR (0.44) TYRHTTHPGDIDO1SMN1; SMN2
Bromide SCHEMBL10807840 0.87 TYR (0.42) TYRHTTHPGDIDO1SMN1; SMN2
Hydrochloric Acid SCHEMBL967243 0.87 TYR (0.42) TYRHTTHPGDIDO1SMN1; SMN2
SCHEMBL10726396 0.86 TYR (0.38) TYRHTTHPGDIDO1SMN1; SMN2
SCHEMBL92099 0.81 ACHE (0.40) TYRHTTHPGDIDO1SMN1; SMN2
SCHEMBL424555 0.81 RAB9A (0.39) TYRHTTHPGDALDH1A1CYP2C9
Hydrochloric Acid SCHEMBL6675199 0.79 ACHE (0.39) TYRHTTHPGDIDO1SMN1; SMN2
Bromide SCHEMBL30579933 0.79 ACHE (0.39) TYRHTTHPGDIDO1SMN1; SMN2
SCHEMBL130924 0.79 ACHE (0.36) TYRHTTHPGDSMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260124318-A1 POLYMERIC MATERIAL AND PREPARATION METHOD THEREOF, AND DRUG-LOADING MATERIAL SOUTHERN UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2026-05-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260124318-A1 POLYMERIC MATERIAL AND PREPARATION METHOD THEREOF, AND DRUG-LOADING MATERIAL FLT4, PF4, PYGL TYR 4811/4885HTT 4221/4885HPGD 3997/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.